In 2023, the average hospital length of stay for dorsalgia cases in France was approximately 4.7 days. The forecast data from 2024 to 2028 suggests a gradual decline from 4.6 days in 2024 and 2025 to 4.4 days in 2028. This indicates a consistent slight decrease in the average length of stay, with a compound annual growth rate (CAGR) reflecting this downward trend over the five-year period.
- The decline from 2024 to 2025 is steady with no change in days.
- From 2025 to 2026, and from 2026 to 2027, the average stay decreases by approximately 2.17% each year.
- Between 2027 and 2028, the length shows another decrement of 2.22%.
Future trends to watch for include advancements in medical treatment protocols, rehabilitation practices, and hospital management efficiencies, which may continue to reduce the average length of stay. Additionally, the integration of telemedicine and outpatient care could further impact these dynamics significantly.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
